DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAFoundation

Neurological complications of nutritional deficiency

Essential points for quick revision.

Synopsis

Recognise deficiency-related neuropathy, myelopathy, ataxia and encephalopathy, identify malabsorption and functional deficiency, and replace nutrients urgently without masking a second diagnosis or causing refeeding harm.

  • Vitamin B12 deficiency can cause peripheral neuropathy, optic neuropathy, cognitive or psychiatric change and subacute combined degeneration, sometimes with a normal haemoglobin and mean cell volume.
  • Posterior-column sensory loss plus corticospinal signs suggests B12 or copper-related myelopathy; a clear sensory level, sphincter dysfunction or rapid progression still requires urgent spinal imaging.
  • Thiamine deficiency causes Wernicke encephalopathy, painful or weak neuropathy and cardiovascular beriberi; treat suspected neurological deficiency parenterally before or alongside carbohydrate when feasible rather than awaiting a blood concentration, without delaying emergency glucose.

Key red flags

Confusion, eye-movement abnormality or acute ataxia in malnutrition or alcohol dependence requires immediate parenteral thiamine before or alongside planned glucose-containing nutrition, while urgent hypoglycaemia is corrected without delay.

Investigation priorities

01
Total or active vitamin B12First step

Identify confirmed or indeterminate B12 status using the current NICE diagnostic thresholds and clinical context.

Management branches

B12Neurological B12 deficiency

Paraesthesia, sensory ataxia, myelopathy, optic or cognitive symptoms occur with confirmed or strongly suspected B12 deficiency.

  1. Take total or active B12, full blood count and cause-directed samples before treatment when this creates no harmful delay and document supplements and nitrous oxide.
  2. Start intramuscular hydroxocobalamin promptly for significant neurological disease using the BNF or local loading regimen and do not wait for macrocytosis.

Key medicines

HydroxocobalaminFor B12 deficiency with neurological involvement, give 1 mg intramuscularly on alternate days until no further improvement, then use the cause-appropriate maintenance schedule, commonly 1 mg every 2 months for irreversible malabsorption.
Folic acidFor confirmed folate deficiency, a common adult regimen is 5 mg orally once daily for 4 months, with longer treatment when the cause persists under specialist guidance.
Open full textbook Answer 2 questions
Sources and review status6 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom